Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumab

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [R01 AI046464, R01 AI114701]
2. Research Facilities Improvement Program grant from National Center for Research Resources, NIH [C06 RR016226]